Characterization of a mechanism to inhibit ovarian follicle activation

Sarah J Barilovits1, Kimberly J Newsom2, Justin S Bickford2

  • 1Department of Neuroscience, College of Medicine, University of Florida, Gainesville, Florida; Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida.

Fertility and Sterility
|February 25, 2014
PubMed
Abstract

Insights

Nutrient deprivation, using 2-deoxyglucose (2-DG), induces Foxo3 expression in ovarian cells and inhibits primordial follicle activation in mice, suggesting potential for fertility preservation.

Area of Science:

  • Reproductive biology and molecular endocrinology.
  • Cellular and molecular mechanisms of follicle development.

Background:

  • Ovarian follicle activation is a critical process in female reproduction.
  • Understanding molecular regulators of follicle activation is key for fertility research.
  • Nutrient deprivation can impact cellular processes, including gene expression.

Purpose of the Study:

  • To investigate if a small molecule, 2-deoxyglucose (2-DG), can induce the transcription factor Foxo3 in ovarian cells.
  • To determine if 2-DG-induced Foxo3 expression inhibits ovarian follicle activation.
  • To explore the potential of this mechanism for fertility preservation strategies.

Main Methods:

  • Utilized cell culture, organ culture, and animal studies with female C57BL/6 mice.
  • Treated human ovarian cells and mouse ovaries with 2-DG to simulate glucose deprivation.
  • Administered varying doses of 2-DG to mice and analyzed gene expression (Foxo3, ATF4, etc.) and follicle counts.

Main Results:

  • 2-deoxyglucose (2-DG) significantly induced Foxo3 expression at both mRNA and protein levels in human ovarian cells.
  • 2-DG treatment also upregulated Foxo3 in ovarian organ cultures.
  • In mice, 2-DG administration led to a 2.6-fold increase in ovarian Foxo3 and a 58% reduction in primordial follicle activation.

Conclusions:

  • Nutrient deprivation, mimicked by 2-DG, effectively induces Foxo3 expression across in vitro and in vivo models.
  • 2-DG treatment in mice inhibits primordial follicle activation, mediated by Foxo3 induction.
  • These findings highlight the potential therapeutic application of 2-DG for fertility preservation.

Related Concept Videos

Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
5.1K
Folliculogenesis01:20

Folliculogenesis

Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...
3.8K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.4K
Oogenesis01:22

Oogenesis

Oogenesis,  the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
5.0K
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
58.4K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.4K